← Back to Search

Surface Acoustic Waves

Treatment Group for Urinary Tract Infection

N/A
Waitlist Available
Research Sponsored by Rosenblum, Jonathan I., DPM
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently being treated with an indwelling urinary catheter for at least 30 days.
Ability to sign informed consent or have someone authorized to sign informed consent.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This is a double blinded rct to evaluate the effect of the UroShield SAW transducer on preventing bacterial colonization in longterm indwelling catheters. The duration of the trial is 30 days. The investigator will be quantifying the number of bacterial colonies in the urinary catheter and in the bladder in both the treatment and control group.

Eligible Conditions
  • Urinary Tract Infection
  • Bacterial Colonization

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bacterial Colonization

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Treatment GroupActive Control1 Intervention
At catheter replacement subjects will have an active UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization.
Group II: Control GroupPlacebo Group1 Intervention
At catheter replacement subjects will have a sham UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization.

Find a Location

Who is running the clinical trial?

Rosenblum, Jonathan I., DPMLead Sponsor
3 Previous Clinical Trials
105 Total Patients Enrolled
NanovibronixIndustry Sponsor
5 Previous Clinical Trials
388 Total Patients Enrolled
2 Trials studying Urinary Tract Infection
224 Patients Enrolled for Urinary Tract Infection

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Mar 2025